GlassScriptPhysician profile
Steven T Atkins
NPI 1245276336
$9,388.49
in general payments reported to CMS, 2019-2025
53 companies · $1,983 in 2025
The $1,983 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $429 · 2021: $1,206 · 2022: $1,683 · 2023: $1,454 · 2024: $1,828 · 2025: $1,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,265.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,467.57 | 2021-2025 | Qulipta, Ubrelvy, Duopa |
| Ucb, INC. | $1,077.49 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Acadia Pharmaceuticals INC | $802.55 | 2019-2025 | Nuplazid |
| Ipsen Biopharmaceuticals, INC | $400.25 | 2022-2024 | Dysport |
| Argenx US, INC. | $398.96 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $316.65 | 2021-2025 | |
| Amgen INC. | $315.97 | 2019-2025 | Uplizna, Aimovig |
| Neurelis, INC. | $315.82 | 2021-2025 | Valtoco |
| Ge Healthcare | $312.95 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $304.89 | 2021-2024 | Ultomiris, Soliris |
| Mdd US Operations, LLC | $294.63 | 2019-2025 | Gocovri, Apokyn, Xadago |
| Janssen Pharmaceuticals, INC | $286.59 | 2019-2022 | |
| Pfizer INC. | $277.06 | 2023-2025 | |
| Horizon Therapeutics Plc | $177.22 | 2021-2023 | Uplizna |
| Novartis Pharmaceuticals Corporation | $166.03 | 2019-2025 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Atkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.